Third Quarter 2023 2 Progress on Strategic Priorities 4 Adjusted EBITDA* 123.5M5CoreSalesGrowth∗0.8123.5M 5 Core Sales Growth* 0.8% − Western Europe delivered DD growth − Continue to invest in long-term growth initiatives • Orthodontics − Spark continues to outperform; Strong growth in Europe & North America • Implant-based Tooth Replacements 20.8% 19.7% • Profitability investments in Spark acceleration & other growth initiatives Adjusted Operating Profit Margin* Sales Adjusted Operating Margin (123.5M5CoreSalesGrowth∗0.8 m) 26.1% 24.6% Q3 2022 Q3 2023 • P ...